Skip to main content

07 Mar MC Services to support BIO-Europe Spring® 2018 as media partner

Munich/Düsseldorf, Germany, March 7, 2018. MC Services AG, the international public relations and investor relations firm, announced today that it will support, as a media partner, BIO-Europe Spring® 2018, Europe’s largest springtime partnering conference for the global biotechnology industry. The event, organized by EBD Group will take place from March 12-14, 2018 at the Amsterdam RAI Convention Center, Amsterdam, The Netherlands.

As media partner, MC Services invites local and international journalists to the event and provides them with information on presenting companies, their executives and investors. MC Services will be on site throughout the conference, conducting both media and partnering meetings.

“We are very happy to continue our well-established collaboration with EBD and to once again support BIO-Europe Spring®, one of the key partnering conferences of the European biotech industry, as a media partner”, said Anne Hennecke, Managing Partner at MC Services. “BIO-Europe Spring® provides an excellent platform, and many opportunities, to network with investors, partners, fellow industry executives and leading sector reporters. With a record number of sector journalists expected to attend this spring meeting, we look forward to helping raise the global awareness of this event, the participating companies and the sector as a whole.”

BIO-Europe Spring® attracts an international “who’s who” from the biotech, pharma and finance sectors, along with the most exciting emerging companies. Based on previous years’ numbers, BIO-Europe Spring® 2018 is expected to draw over 2,500 pharma and biotech executives seeking valuable partnerships and investment, who will participate in a projected 15,000+ one-to-one meetings during the three-day conference. More than 115 company presentations and over 20 high-level workshops and panel discussions will round off the event. Furthermore, high level speakers will share their experience and opinions on neurodegeneration treatments, navigating Brexit, antimicrobials and vaccines, the impact of patient advocacy organizations, immuno-oncology, alternative financing, and new opportunities in China. For detailed information regarding the program, timing and location, please visit the event’s website.